Definitive Contract 75N91024C00077
Award Date 9/16/24
Potential Completion Date 9/15/25
Potential Value $390K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
17
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- This is a $454,183 firm fixed-price contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Inbios International Inc., a minority-owned, for-profit biotechnology company based in Seattle, Washington. The contract, which is set aside for small businesses, is for the development of a rapid at-home test to detect prostate-specific antigen using self-collected finger stick blood. This contract was awarded under the NCI's Small Business...
- This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Triton Systems, Inc., a global product development and venturing company. The $399,925 firm-fixed-price contract is for the development of a low-cost, point-of-care detection device for prostate-specific antigen using a paper-based flow assay. This SBIR Phase I contract is part of the NCI's research efforts to...
- This federal contract award, identified as HHSN261201200069C, was issued by the National Cancer Institute (NCI), a civilian agency, to Pharmaseq, Inc., a small business, for the development of a "Multiplex Prostate Cancer Serum Assay on RFID P-Chips" under the SBIR (Small Business Innovation Research) Program Phase I. The award, valued at $199,909.00 on a firm fixed-price basis, has a completed date of September 27, 2013. The contract is designated as a total small business set-aside.
- The National Cancer Institute awarded a $455,000 firm fixed-price contract to Oncobiomix Inc., a small business located in San Antonio, Texas, under the Small Business Innovation Research (SBIR) Program Phase I. The award, issued on September 11, 2024, supports research and development of OnCobiomix, a microbiome-based diagnostic test designed to assess prostate cancer risk. As a Phase I SBIR award, this contract represents an initial feasibility and proof-of-concept stage, with a completion...
- This federal contract award was made by the National Cancer Institute (NCI), a civilian agency, to Physical Sciences Inc. (PSI), a for-profit research and development company. The $198,397.00 contract is a Small Business Innovation Research (SBIR) Program Phase I action, with a firm fixed price. The award date was September 24, 2010, and the ultimate completion date was January 23, 2012. PSI has extensive experience supporting government agencies through prime contracts, subcontracts, and...
- This is a Small Business Innovation Research (SBIR) Phase I contract for $248,077.00 awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Electronic Biosciences, Inc., a for-profit organization located in San Diego, CA. The contract is for the development of nanoscale tools for RNA modification sequencing. Electronic Biosciences has previously received federal grants and contracts from...
- This $382,537.00 federal contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Intelligent Optical Systems, Inc. for a Small Business Innovation Research (SBIR) Phase I project on developing a fingerstick blood test for the point-of-care detection of prostate-specific antigen. The contract has a set-aside for small businesses and a completion date of September 15, 2025. Intelligent Optical Systems, Inc. is a manufacturer of optical...
- This is a $389,973 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Ai Biosciences, Inc., a small disadvantaged biotechnology company. The contract is for the development of a "Rapid Isothermal Amplification Chip for HPV Detection and Genotyping in Low-Resource Settings." This aligns with NCI's mission to support cancer research and diagnostic technologies,...
- This $400,000 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Amplifidx Inc., a woman-owned small business. The contract supports the development of cancer prevention and diagnosis technologies for low-resource settings over a two-year period. This award aligns with NCI's mission to support innovative medical device research and development by small businesses. As a SBIR...
- <p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>